Topics

No keywords indexed for this article. Browse by subject →

References
42
[7]
Models for Predicting Effective HIV Chemoprevention in Women

Melanie R. Nicol, Cindi W. Emerson, Heather M. A. Prince et al.

JAIDS Journal of Acquired Immune Deficiency Syndro... 10.1097/qai.0000000000000472
[30]
Vonesh EFaC VM (1997)
[31]
Davidian MaG DM (1995)
[34]
Environmental Protection Agency: Guidance for Data Quality Assessment. (Edited by Office of Environmental Information). Washington DC, Environmental Protection Agency, 2000, pp. 153–165.
[37]
McGowan I Curr Top Microbiol Immunol (2014)
[38]
Expression of six drug transporters in vaginal, cervical, and colorectal tissues: Implications for drug disposition in HIV prevention

Melanie R. Nicol, Yuri Fedoriw, Michelle Mathews et al.

The Journal of Clinical Pharmacology 10.1002/jcph.248
[40]
Thurman AR J Acquir Immune Defic Syndr
[41]
Reed LJ Am J Hygiene (1938)
Cited By
16
AIDS Research and Human Retroviruse...
Metrics
16
Citations
42
References
Details
Published
Apr 01, 2017
Vol/Issue
33(4)
Pages
395-403
Cite This Article
Nicola Richardson-Harman, Robert Parody, Peter Anton, et al. (2017). Analytical Advances in the Ex Vivo Challenge Efficacy Assay. AIDS Research and Human Retroviruses, 33(4), 395-403. https://doi.org/10.1089/aid.2016.0073